Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleGleevec loses Indian patent battle.AuthorsJayaraman, KillugudiAbstractThe article presents a court case wherein the Supreme Court in India has rejected the extension of patent protection filed by Novartis for its leukemia drug Gleevec or Glivec (imatinib).SubjectsINDIA. Supreme Court; NOVARTIS AG; PATENTS; ACTIONS &; defenses (Law)PublicationNature Biotechnology, 2013, Vol 31, Issue 5, p371ISSN1087-0156Publication typeArticleDOI10.1038/nbt0513-371b